Vall D'hebron Institute Of Oncology
Clinical trials sponsored by Vall D'hebron Institute Of Oncology, explained in plain language.
-
Cancer drug combo shows promise for Hard-to-Treat bowel cancer
Disease control TerminatedThis study tested a combination of two drugs, atezolizumab and bevacizumab, in 46 people with advanced colorectal cancer that had stopped responding to chemotherapy and had a specific genetic feature called MSI-like. The goal was to see if the treatment could shrink tumors. The s…
Phase: PHASE2 • Sponsor: Vall d'Hebron Institute of Oncology • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Experimental immune cell combo for tough breast cancer stalls after just 2 patients
Disease control TerminatedThis early-phase trial tested whether adding donor natural killer (NK) cells to the standard antibody drugs trastuzumab and pertuzumab could help people with advanced HER2-positive breast cancer that had stopped responding to other treatments. Only 2 participants were enrolled be…
Phase: PHASE1 • Sponsor: Vall d'Hebron Institute of Oncology • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC